Metabolic & Cardiometabolic · Gut & Microbiome
oral bile acid (CDCA) increases GLP-1
In plain terms: Does an oral bile acid boost the gut hormone GLP-1 in people?
Probably yes for the bile acid itself, but whether ordinary diet can do the same is unproven.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Human trials (RCT / n-of-1)
How the studies fall
What the evidence shows
Direct chenodeoxycholic acid raises GLP-1 in humans (intragastric, and post-RYGB), but bile-acid SEQUESTRANTS do not raise GLP-1 in humans despite lowering glucose — so the human glucose benefit of sequestrants is not GLP-1-mediated. Bile acids CAN drive human GLP-1; whether diet can is unproven.
The evidence (17)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Kuhre 2018 · Mol Metab | animal | supports | moderate | Bile acids are direct and indirect regulators of GLP-1 and other gut/pancreatic hormone secretion. |
| Smushkin G et al] # corrected 2026-08-17 from PubMed; was [(colesevelam RCT) 2013 · (human RCT) | RCT | tested-null | moderate | n=38 RCT 12wk: improved glycemia but postprandial GLP-1 UNCHANGED (mechanism = glucose sequestration) |
| Beysen C et al] # corrected 2026-08-17 from PubMed; was [Hansen 2012 · Diabetologia | RCT | supports | moderate | Colesevelam improved glucose metabolism with bile-acid-mediated GLP-1 mechanism in type-2 diabetes RCT. |
| Sun YH et al 2026 · study_type: animal | animal | mixed | low | Mouse MASLD model: herbal decoction (LGZG) enriched endogenous non-12-OH bile acids (HCA, 7-ketoLCA), known TGR5 agonists; serum GLP-1 elevated (p<0.05) alongside adipose TGR5-cAMP/PKA/CREB activation. |
| Christiansen 2019 · Am J Physiol Gastrointest | animal | supports | moderate | Bile acids drive colonic GLP-1 and PYY secretion 3.5x via basolateral TGR5 in perfused rat/mouse colon. |
| Roberts 2011 · Clin Endocrinol | observational | supports | moderate | Postprandial bile acid concentrations correlate with GLP-1 and PYY secretion in humans. |
| Murakami 2013 · SpringerPlus | observational | supports | low | Oral ursodeoxycholic acid with a meal raised GLP-1 secretion and lowered blood glucose in non-diabetic humans. |
| Lv J et al 2026 · study_type: animal | animal | tested-null | moderate | Mouse: oral UDCA recapitulated anti-obesity/metabolic benefits of BSH-probiotic; UDCA acted as intestinal FXR antagonist + TGR5 agonist, stimulated GLP-1 secretion; HepG2 cells showed UDCA directly activates GLP-1 receptor. |
| Nielsen S et al] # corrected 2026-08-17 from PubMed; was [(CDCA post-RYGB) 2017 · (human crossover) | RCT | supports | moderate | Oral CDCA raised GLP-1/PYY/FGF19 in post-RYGB (n=11); UDCA did not |
| Bronden 2018 · Diabetes Obes Metab | RCT | mixed | high | Sevelamer (bile-acid sequestrant) abolished the acute endogenous-bile-acid GLP-1 stimulus in T2D-confirms bile acids drive GLP-1. |
| Hansen M, et al. (Knop) 2016 · (human crossover) | RCT | supports | moderate | Intragastric CDCA increased plasma GLP-1 (human crossover) |
| Wu 2013 · Diabetes Obes Metab | RCT | supports | moderate | Rectal taurocholic acid dose-dependently stimulated GLP-1 and PYY in healthy men. |
| Ma H et al 2026 · study_type: animal | animal | mixed | moderate | 46 obesity-prone humans had depleted GDCA (observational only, no GLP-1 measured in humans); FMT-recipient + GDCA-supplemented mice: GDCA activated TGR5, increased ileal GLP-1 secretion and BAT thermogenesis. |
| Gether IM et al] # corrected 2026-08-17 from PubMed; was [(Knop, colesevelam) 2024 · (human crossover) | RCT | tested-null | moderate | Single-dose colesevelam: no acute postprandial GLP-1 rise |
| She J, et al. 2024 · Cell Metab | mechanism | mixed | high | Statin-driven bile-acid/microbiome shifts reduce GLP-1 and worsen insulin resistance-supports bile-acid-GLP-1 axis indirectly. |
| Brighton CA, et al. 2015 · Endocrinology | mechanism | supports | moderate | Bile acids trigger GLP-1 release predominantly via basolateral GPBAR1/TGR5 on L-cells. |
| Trabelsi MS, et al. 2015 · Nat Commun | in-vitro | contradicts | moderate | FXR activation (a bile-acid receptor) INHIBITS GLP-1 production by L-cells-bile-acid effect on GLP-1 is receptor-dependent and bidirectional. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.